Tag: Hepatitis
IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons With HIV
Seroprotection rate increased from 94.4 percent at eight weeks after second dose to 98.5 percent at week 24
HIV + Hep C Coinfection Not Tied to Increased Type 1 MI Risk
However, with increasing age, risk for type 1 myocardial infarction increased for people with HIV with versus without hepatitis C virus infection
Few Insured Individuals Receive Timely DAA Treatment for Hep C
Individuals with Medicare and Medicaid have lower odds of treatment initiation than those with private insurance
Hep C Reinfection Low Among People Receiving Opioid Agonist Therapy
Rate of hepatitis C virus reinfection higher among people with recent injecting drug use
Two Case Series Describe Acute Pediatric Hepatitis of Unknown Cause
Unclear whether human adenovirus is the causative agent for acute hepatitis in these children
Treatment for Hep C Up Among People Who Inject Drugs
Among PWID with chronic HCV infection, proportion with detectable HCV RNA decreased from 100 percent in 2006 to 48 percent in 2019
Children <12 Need Not Repeat HIV, Hep B/C Tests Before Transplant Surgery
Candidates aged <12 years at the time of transplantation are exempt from testing if they received postnatal infectious disease testing
296 Children Had Hepatitis of Unknown Etiology by June 15, 2022
Overall, 89.9 percent of patients under investigation were hospitalized, 6.1 percent required a transplant, and 3.7 percent died
Progress Seen in Proportion of Pregnant Persons With Hep C Screening
Percentage undergoing HCV screening test increased from 16.6 percent in quarter 1 of 2011 to 40.6 percent in quarter 2 of 2021
No Increase Seen in Pediatric Hepatitis in the United States
No increase in acute hepatitis of unspecified etiology, adenovirus types 40/41 above prepandemic baseline levels
